141 related articles for article (PubMed ID: 23316253)
1. Novel advances in dermatitis herpetiformis.
Fabbri P; Calabrò AS; Hashimoto T; Fasano A; Caproni M
Clin Dev Immunol; 2012; 2012():450109. PubMed ID: 23316253
[No Abstract] [Full Text] [Related]
2. Comment on "Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology".
Antiga E; Caproni M; Fabbri P
J Immunol; 2011 Jul; 187(2):595; author reply 595-6. PubMed ID: 21734078
[No Abstract] [Full Text] [Related]
3. [Dermatitis herpetiformis antibodies: What the dermatologist must know].
Ingen-Housz-Oro S; Amiot A; Ortonne N; Hüe S
Ann Dermatol Venereol; 2014 May; 141(5):387-91. PubMed ID: 24835656
[No Abstract] [Full Text] [Related]
4. Management of dermatitis herpetiformis.
Cardones AR; Hall RP
Immunol Allergy Clin North Am; 2012 May; 32(2):275-81, vi-vii. PubMed ID: 22560140
[TBL] [Abstract][Full Text] [Related]
5. IgA anti-epidermal transglutaminase antibodies in dermatitis herpetiformis and pediatric celiac disease.
Jaskowski TD; Hamblin T; Wilson AR; Hill HR; Book LS; Meyer LJ; Zone JJ; Hull CM
J Invest Dermatol; 2009 Nov; 129(11):2728-30. PubMed ID: 19516268
[No Abstract] [Full Text] [Related]
6. [Dermatitis herpetiformis].
Gómez Sánchez ME; Faura Berruga C; Iñiguez de Onzoño Martín L; Nam Cha S
Med Clin (Barc); 2014 Dec; 143(11):e21. PubMed ID: 24947204
[No Abstract] [Full Text] [Related]
7. [Dermatitis herpetiformis].
Juratli HA; Görög A; Sárdy M
Hautarzt; 2019 Apr; 70(4):260-264. PubMed ID: 30868254
[TBL] [Abstract][Full Text] [Related]
8. Dermatitis Herpetiformis: Novel Perspectives.
Antiga E; Maglie R; Quintarelli L; Verdelli A; Bonciani D; Bonciolini V; Caproni M
Front Immunol; 2019; 10():1290. PubMed ID: 31244841
[TBL] [Abstract][Full Text] [Related]
9. Sensitivity of Transglutaminase 3 in the IgA Aggregates in Dermatitis Herpetiformis Skin to Potassium Iodide.
Taylor TB; Zone JJ
J Invest Dermatol; 2018 Sep; 138(9):2066-2068. PubMed ID: 29571943
[No Abstract] [Full Text] [Related]
10. Is dermatitis herpetiformis changing?
Antiga E; Fabbri P; Caproni M
G Ital Dermatol Venereol; 2013 Apr; 148(2):159-62. PubMed ID: 23588140
[No Abstract] [Full Text] [Related]
11. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue.
Marietta EV; Camilleri MJ; Castro LA; Krause PK; Pittelkow MR; Murray JA
J Invest Dermatol; 2008 Feb; 128(2):332-5. PubMed ID: 17762854
[TBL] [Abstract][Full Text] [Related]
12. Dermatitis herpetiformis: from the genetics to the development of skin lesions.
Bonciani D; Verdelli A; Bonciolini V; D'Errico A; Antiga E; Fabbri P; Caproni M
Clin Dev Immunol; 2012; 2012():239691. PubMed ID: 22778763
[TBL] [Abstract][Full Text] [Related]
13. Proceedings: Immunological phenomena following gluten challenge in the jejunum of patients with adult coeliac disease and dermatitis herpetiformis.
Lancaster-Smith M; Kumar P; Clark ML
Gut; 1974 Apr; 15(4):339. PubMed ID: 4599875
[No Abstract] [Full Text] [Related]
14. Fibrillar IgA deposition in dermatitis herpetiformis--an underreported pattern with potential clinical significance.
Ko CJ; Colegio OR; Moss JE; McNiff JM
J Cutan Pathol; 2010 Apr; 37(4):475-7. PubMed ID: 19919655
[TBL] [Abstract][Full Text] [Related]
15. IgA antiepidermal transglutaminase antibodies in dermatitis herpetiformis: a significant but not complete response to a gluten-free diet treatment.
Reunala T; Salmi TT; Hervonen K; Laurila K; Kautiainen H; Collin P; Kaukinen K
Br J Dermatol; 2015 Apr; 172(4):1139-41. PubMed ID: 25196300
[No Abstract] [Full Text] [Related]
16. Novel therapeutic/integrative approaches for celiac disease and dermatitis herpetiformis.
Fasano A
Clin Dev Immunol; 2012; 2012():959061. PubMed ID: 23093980
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis.
Dieterich W; Laag E; Bruckner-Tuderman L; Reunala T; Kárpáti S; Zágoni T; Riecken EO; Schuppan D
J Invest Dermatol; 1999 Jul; 113(1):133-6. PubMed ID: 10417632
[TBL] [Abstract][Full Text] [Related]
18. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescent findings.
Beutner EH; Baughman RD; Austin BM; Plunkett RW; Binder WL
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 2):329-32. PubMed ID: 10901714
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase antibodies in dermatitis herpetiformis.
Porter WM; Unsworth DJ; Lock RJ; Hardman CM; Baker BS; Fry L
Gastroenterology; 1999 Sep; 117(3):749-50. PubMed ID: 10490368
[No Abstract] [Full Text] [Related]
20. Dermatitis herpetiformis and the mucosal immune response.
Hall RP
J Autoimmun; 1991 Feb; 4(1):47-58. PubMed ID: 2031663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
